Pillstats
Rx only · Patch, Extended Release · Transdermal

Fentanyl

Fentanyl

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN01AH01
RxCUI (US)4337
US makers2 labelers
Packages16
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$4.69$9.37$14.06$18.75Dec 2025Apr 2026Jul 2026
$15.230
Latest avg · Jul 22, 2026
-7%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.7K5.4K8.0K11K2025 Q12025 Q22025 Q32025 Q42026 Q1
8.8K
Rx · 2026 Q1
81K
Units dispensed
+549%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aveva Drug Delivery Systems Inc.unknown8SUPPLYING
Ingenus Pharmaceuticals, LLCunknown8SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.